The study will enroll up to 3 sites in Latin America, enrollment is competitive.~Up to 70 subjects will receive treatment and be followed through their 3-month visit.~Long-term follow-up will continue every 6 months out to 2 years post-procedure, with an option to follow patients up to 5 years.
This is a prospective, multicenter, non-randomized single-arm safety and efficacy study to:~Collect data to evaluate the safety of CHILLS cryotherapy to treat OSA in patients with moderate to severe disease.~Evaluate the chronic performance of the CHILLS system and collect clinical measures for therapy effectiveness that will be used to demonstrate safety and effectiveness in the next clinical study.